imcivree
(setmelanotide)Rhythm Pharmaceuticals, Inc
Usage: IMCIVREE is indicated for chronic weight management in adults and pediatric patients aged 6 and older with obesity due to specific genetic disorders (POMC, PCSK1, LEPR deficiencies) or Bardet-Biedl syndrome. It is not effective for other obesity types or cases with benign genetic variants.